The impacts of vaccination status and host factors during early infection on SARS-CoV-2 persistence: a retrospective single-center cohort study
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2022.04.14.22273860: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: Ethics statement: This study was approved by the Research Ethics Review Committee (Ethics Approval Number: YJ-2020-S080-02) of the Shanghai Public Health Clinical Center Affiliated to Fudan University. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Bioperfectus technologies Co., LTD., Jiangsu, China) and ABI 7500 real-time fluorescence quantitative PCR (qPCR) instrument (Thermo Fisher Technology Co. Thermo Fisher Technology Cosuggested: NoneAll the statistical analyses were conducted using Graphpad Prism 9 (GraphPad Software, USA). Graphpad Prismsuggested: …SciScore for 10.1101/2022.04.14.22273860: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: Ethics statement: This study was approved by the Research Ethics Review Committee (Ethics Approval Number: YJ-2020-S080-02) of the Shanghai Public Health Clinical Center Affiliated to Fudan University. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Bioperfectus technologies Co., LTD., Jiangsu, China) and ABI 7500 real-time fluorescence quantitative PCR (qPCR) instrument (Thermo Fisher Technology Co. Thermo Fisher Technology Cosuggested: NoneAll the statistical analyses were conducted using Graphpad Prism 9 (GraphPad Software, USA). Graphpad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Several limitations of the present study should be noted. First, antigen-specific immune responses were not detected in this retrospective work. Nonetheless, we speculate that the vaccine induce immunities might not be able to constrain viral RNA shedding in mild COVID-19 patients, since both an inactivated vaccine and an mRNA vaccine failed to shorten the duration of viral RNA shedding in these patients. Second, although a previous study showed that viral RNA load (>107 copies/ml) is an independent risk factor for live virus shedding (35), the detection viral RNA might not always indicate the presence of live viruses. Further investigations are necessitated to characterize host factors that associate with the shedding of viable viruses. Third, most cases enrolled in this study were infected by either the D614G variant or the Delta variant, but we were not able to define the infected variant for each case. Therefore, the impact of viral factor on the duration of viral RNA shedding is out-of-scope for this study. Despite of these limitations, our study showed for the first time that COVID-19 vaccines contributed to the clearance viral RNA in moderate cases, while failed to shorten the duration of viral RNA shedding in mild patients. Moreover, we identified a set of laboratory variables in early infection that could predict the persistence of viral RNA. These findings may serve as a rationale to optimize the control measures for COVID-19 pandemic.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a protocol registration statement.
Results from scite Reference Check: We found no unreliable references.
-